Policies & Regulations

Improving Vaccine Safety: Challenges and Reforms Needed
Clinical & Pharma Improving Vaccine Safety: Challenges and Reforms Needed

Research into vaccine safety has gained critical importance in recent years, particularly following the widespread deployment of COVID-19 vaccinations. Dual challenges have emerged, involving inadequate monitoring of adverse effects and insufficient compensation for those affected. These challenges

Can CDC's Crisis Undermine HIV Research Progress?
Clinical & Pharma Can CDC's Crisis Undermine HIV Research Progress?

The Centers for Disease Control and Prevention (CDC) has recently faced considerable disruption, raising alarm and uncertainty across the spectrum of ongoing HIV research initiatives. The upheaval started with abrupt layoffs of several key HIV specialists, only to be followed by sudden

Is the NIH Trapped in Politics Under Trump's Shadow?
Management & Administration Is the NIH Trapped in Politics Under Trump's Shadow?

In an astonishing turn of events, the Bethesda Declaration by the National Institutes of Health (NIH) staff in Bethesda, Maryland, made waves amid ongoing political tensions. Set against the backdrop of dissent against policies introduced during Donald Trump’s presidency, the letter calls for a

Future of Mental Health Parity Hinges on Trump Administration Decision
Management & Administration Future of Mental Health Parity Hinges on Trump Administration Decision

The Trump administration is at a critical crossroads, facing a monumental decision on regulations designed during the Biden era to uphold mental health parity in insurance coverage. For nearly two decades, proponents of mental health parity have championed its realization, striving to ensure that

California's School Mental Health Initiative Faces Delays
Management & Administration California's School Mental Health Initiative Faces Delays

California's ambitious effort to transform mental health services in schools through the Children's and Youth Behavioral Health Initiative Fee Schedule Program has encountered significant hurdles, casting uncertainty over its rollout. Launched as part of a broader $4.7 billion initiative in 2021,

Trump's FDA and Medtech: Changes, Challenges, and Impact
Management & Administration Trump's FDA and Medtech: Changes, Challenges, and Impact

With the arrival of President Donald Trump's administration, the medical technology (medtech) industry faced a series of policy and regulatory transformations primarily steered by the U.S. Food and Drug Administration (FDA) and the Department of Health and Human Services (HHS). These changes

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later